Gary Zammit

10.4k citations

117 papers · 7.0k indexed · 3 hit papers · h-index 40

Impact in

Endocrine and Autonomic Systems top 0.1%
- Circadian rhythm and melatonin
- Neuroscience of respiration and sleep
Experimental and Cognitive Psychology top 0.1%
- Sleep and related disorders
- Sleep and Work-Related Fatigue

Papers in

Experimental and Cognitive Psychology 87
- Sleep and related disorders 85
- Sleep and Work-Related Fatigue 15
Endocrine and Autonomic Systems 41
- Circadian rhythm and melatonin 29
- Neuroscience of respiration and sleep 8

Co-authors: Dolores Malaspina James E. Gangwisch Felix Kreier Thomas G. Pickering Bernadette Boden‐Albala Andrew Rundle Steven B. Heymsfield Ruud M. Buijs
Journals: SLEEP (28 papers)Sleep Medicine (14 papers)Journal of Clinical Sleep Medicine (10 papers)Journal of Sleep Research (4 papers)CHEST Journal (3 papers)
Partner nations: United States France Switzerland

In The Last Decade

Gary Zammit

112 papers receiving 6.7k citations

Hit Papers

align trajectories log scale

Safety and efficacy of daridorexant in patients with insomnia disorder: results from two multicentre, randomised, double-blind, placebo-controlled, phase 3 trials 2022 · 136 citations

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if any of the following hold:

it has ≥500 total citations;
it reaches ≥1.5× the top-1% citation threshold for papers in the same subfield and year (the threshold is the minimum needed to enter the top 1%, not the average within it);
it reaches the top citation threshold in at least one of its specific research topics.

2022 The Lancet Neurology
2016 International Journal of Obesity
2006 Hypertension

Peers

Countries citing papers authored by Gary Zammit

Since Specialization

Citations

This map shows the geographic impact of Gary Zammit's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gary Zammit with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gary Zammit more than expected).

Fields of papers citing papers by Gary Zammit

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gary Zammit. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gary Zammit. The network helps show where Gary Zammit may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Gary Zammit, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Gary Zammit Line = papers co-authored together Gary Zammit links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Effect of daridorexant on sleep architecture in patients with chronic insomnia disorder: a pooled post hoc analysis of two randomized phase 3 clinical studies SLEEP ·Skyler G. Cruz, Ina Djonlagic, Yves Dauvilliers, Dominik J. Frank, Addien Fikriansyah, Alexandre Datta, Jeffrey Hubbard, Göran Hajak, Andrew D. Krystal, María Luz López Llano, Liborio Parrino, Corey B. Puryear, Gary Zammit, Jacob Donoghue, Thomas E. Scammell	2024	5
2	Effect of lemborexant on sleep architecture in participants with insomnia disorder and mild obstructive sleep apnea Sleep Medicine ·Clete A. Kushida, Gary Zammit, Jocelyn Y. Cheng, D. Picard, Margaret Moline	2024	5
3	0354 Effect of Lemborexant on Sleep Architecture in Subjects with Comorbid Insomnia and Mild Obstructive Sleep Apnea from a Ph 3 Trial SLEEP ·Clete A. Kushida, Gary Zammit, Beryl Miess, D. Picard, Margaret Moline	2023	1
4	Number, Duration, and Distribution of Wake Bouts in Patients with Insomnia Disorder: Effect of Daridorexant and Zolpidem CNS Drugs ·Skyler G. Cruz, Thomas E. Scammell, Jiang Yuan-yang, Dalma Seboek Kinter, Alexandre Datta, Gary Zammit, Yves Dauvilliers	2023	14
5	Safety and efficacy of daridorexant in patients with insomnia disorder: results from two multicentre, randomised, double-blind, placebo-controlled, phase 3 trials The Lancet Neurology ·Emmanuel Mignot, David Mayleben, Ingo Fietze, Damien Léger, Gary Zammit, Claudio L. Bassetti, Scott Pain, Dalma Seboek Kinter, Thomas Roth Hit paper breakdown →	2022	136
6	Comparison of the effect of lemborexant with placebo and zolpidem tartrate extended release on sleep architecture in older adults with insomnia disorder Journal of Clinical Sleep Medicine ·Margaret Moline, Gary Zammit, Jocelyn Y. Cheng, Carlos Perdomo, Dinesh Kumar, David Mayleben	2021	31
7	Incidence and duration of common early-onset adverse events in randomized controlled trials of solriamfetol for treatment of excessive daytime sleepiness in obstructive sleep apnea and narcolepsy Journal of Clinical Sleep Medicine ·Russell Rosenberg, Michael J. Thorpy, Yves Dauvilliers, Paula K. Schweitzer, Gary Zammit, Mark H. Gotfried, Shay Bujanover, José Francisco Mejía Flores, Atul Malhotra	2021	8
8	Effects of Weight Loss on Obstructive Sleep Apnea Severity. Ten-Year Results of the Sleep AHEAD Study American Journal of Respiratory and Critical Care Medicine ·Samuel T. Kuna, David M. Reboussin, Elsa S. Strotmeyer, Richard P. Millman, Gary Zammit, Michael P. Walkup, Thomas A. Wadden, Rena R. Wing, F. Xavier Pi‐Sunyer, Adam P. Spira, Gary D. Foster	2020	77
9	Safety of lemborexant versus placebo and zolpidem: effects on auditory awakening threshold, postural stability, and cognitive performance in healthy older participants in the middle of the night and upon morning awakening Journal of Clinical Sleep Medicine ·Patricia Murphy, Dinesh Kumar, Gary Zammit, Russell Rosenberg, Margaret Moline	2020	49
10	Solriamfetol for Excessive Sleepiness in Obstructive Sleep Apnea (TONES 3). A Randomized Controlled Trial American Journal of Respiratory and Critical Care Medicine ·Paula K. Schweitzer, Russell Rosenberg, Gary Zammit, Mark H. Gotfried, Dan Chen, Lawrence P. Carter, Hao Wang, Yuan Lü, Jed Black, Atul Malhotra, Kingman P. Strohl	2018	111
11	Lemborexant, A Dual Orexin Receptor Antagonist (DORA) for the Treatment of Insomnia Disorder: Results From a Bayesian, Adaptive, Randomized, Double-Blind, Placebo-Controlled Study Journal of Clinical Sleep Medicine ·Patricia Murphy, Margaret Moline, David Mayleben, Russell Rosenberg, Gary Zammit, Kate Pinner, Shobha Dhadda, Quan Hong, Luigi Giorgi, Andrew Satlin	2017	119
12	Effects of a lifestyle intervention on REM sleep‐related OSA severity in obese individuals with type 2 diabetes Journal of Sleep Research ·Ari Shechter, Gary D. Foster, Wei Lang, David M. Reboussin, Marie‐Pierre St‐Onge, Gary Zammit, Anne B. Newman, Richard P. Millman, Thomas A. Wadden, John M. Jakicic, Elsa S. Strotmeyer, Rena R. Wing, F. Xavier Pi‐Sunyer, Samuel T. Kuna	2017	22
13	The Effect of Changes in Cardiorespiratory Fitness and Weight on Obstructive Sleep Apnea Severity in Overweight Adults with Type 2 Diabetes SLEEP ·Christopher E. Kline, David M. Reboussin, Gary D. Foster, Thomas B. Rice, Elsa S. Strotmeyer, John M. Jakicic, Richard P. Millman, F. Xavier Pi‐Sunyer, Anne B. Newman, Thomas A. Wadden, Gary Zammit, Samuel T. Kuna	2016	17
14	Dual Orexin Receptor Antagonist, Almorexant, in Elderly Patients With Primary Insomnia: A Randomized, Controlled Study SLEEP ·Thomas Roth, Jed Black, Raymond Cluydts, Pascal Charef, Priyankita Pant, Khadija Iftikhar, Gary Zammit, James K. Walsh	2016	25
15	Effect of liraglutide 3.0 mg in individuals with obesity and moderate or severe obstructive sleep apnea: the SCALE Sleep Apnea randomized clinical trial International Journal of Obesity ·(unknown), Adam Blackman, Gary D. Foster, Gary Zammit, Russell Rosenberg, Louis J. Aronne, Thomas A. Wadden, Birgitte Claudius, Camilla Jensen, Emmanuel Mignot Hit paper breakdown →	2016	356
16	The Relationship Between Obstructive Sleep Apnea and Self-Reported Stroke or Coronary Heart Disease in Overweight and Obese Adults with Type 2 Diabetes Mellitus SLEEP ·Thomas B. Rice, Gary D. Foster, Matthew R. Sanders, Mark L. Unruh, David M. Reboussin, Samuel T. Kuna, Richard P. Millman, Gary Zammit, Rena R. Wing, Thomas A. Wadden, David E. Kelley, Xavier Pi‐Sunyer, Anne B. Newman	2012	42
17	Nonrestorative Sleep as a Distinct Component of Insomnia SLEEP ·Thomas Roth, Gary Zammit, Alan Lankford, David Mayleben, Theresa Stern, Verne Pitman, David M. Clark, John L. Werth	2010	81
18	Safety and Subjective Sleep Effects of Ramelteon Administration in Adults and Older Adults With Chronic Primary Insomnia The Journal of Clinical Psychiatry ·Gary S. Richardson, Gary Zammit, Sherry Wang‐Weigand, Jeffrey Zhang	2009	40
19	Gender and Body Mass Index as Related to the Night-Eating Syndrome in Obese Outpatients Journal of the American Dietetic Association ·Nancy J. Aronoff, Allan Geliebter, Gary Zammit	2001	71
20	Work-shift period and weight change Nutrition ·Allan Geliebter, Marci E. Gluck, Jennifer Gunning, Nancy J. Aronoff, Gary Zammit	2000	142

About Gary Zammit

Gary Zammit is a scholar working on Experimental and Cognitive Psychology, Endocrine and Autonomic Systems, Cognitive Neuroscience, Physiology and Epidemiology, having authored 117 papers that have together received 7.0k indexed citations. Recurring topics across this work include Sleep and related disorders (85 papers), Sleep and Wakefulness Research (83 papers), Circadian rhythm and melatonin (29 papers), Obstructive Sleep Apnea Research (27 papers), Restless Legs Syndrome Research (17 papers), Sleep and Work-Related Fatigue (15 papers), Neuroscience of respiration and sleep (8 papers) and Obesity, Physical Activity, Diet (6 papers). The work is most often cited by research in Endocrine and Autonomic Systems (2.6k citations), Experimental and Cognitive Psychology (4.6k citations), Cognitive Neuroscience (3.4k citations), Physiology (1.8k citations) and Biological Psychiatry (146 citations). Gary Zammit has collaborated with scholars based in United States, France and Switzerland. Frequent co-authors include Dolores Malaspina, James E. Gangwisch, Felix Kreier, Thomas G. Pickering, Bernadette Boden‐Albala, Andrew Rundle, Steven B. Heymsfield, Ruud M. Buijs, Thomas Roth and Russell Rosenberg. Their work appears in journals such as SLEEP, Sleep Medicine, Journal of Clinical Sleep Medicine, Journal of Sleep Research and CHEST Journal.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact